Ocular Therapeutix (NasdaqGM:OCUL) Q3 2026 Earnings call November 09, 2026 08:00 AM ET Company ParticipantsBill Slattery Jr. - VP of Investor RelationsPravin Dugel - Executive Chairman, President, and CEONadia Waheed - Chief Medical OfficerDavid Robinson - Global Chief Commercial OfficerConference Call ParticipantsBiren Amin - AnalystTazeen Ahmad - AnalystSam Rollenhagen - AnalystLisa Walter - AnalystNick Quartapella - AnalystOperatorGood morning, and welcome to the Ocular Therapeutix third quarter 2026 ear ...